Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses

Zhang, Zhengmao; Qin, Kaiyun; Zhang, Wenzhe; Yang, Botao; Zhao, Chen; Zhang, Xiaojing; Zhang, Fenghua; Zhao, Lianmei; Shan, Baoen

doi:10.1186/s13048-019-0499-z

Journal of Ovarian Research

Table 1 Clinical characteristics of the study subjects

From: Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses

No.	Age	FIGO stage	Histotype	Grade^A	Regimen after primary surgery	Evaluation
1	61	III	Serous	III	Paclitaxel/ Oxaliplatin	Sensitive
2	44	III	Serous	II	Paclitaxel/Nedaplatin	Sensitive
3	60	II	Endometrioid	II	Paclitaxel/Nedaplatin	Sensitive
4	50	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
5	55	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
6	43	I	clear cell carcinomas	II	Paclitaxel/Oxaliplatin	Sensitive
7	51	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
8	59	III	Endometrioid	II	Paclitaxel/Oxaliplatin	Sensitive
9	50	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
10	55	II	Serous	III	Paclitaxel/Oxaliplatin	Sensitive
11	50	I	Serous	III	Paclitaxel/Oxaliplatin	Sensitive
12	56	III	Serous	III	Paclitaxel/Oxaliplatin	Sensitive
13	65	II	Endometrioid	III	Paclitaxel/Nedaplatin	Sensitive
14	58	II	Serous	III	Paclitaxel/Oxaliplatin	Sensitive
15	50	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
16	59	III	Endometrioid	II	Paclitaxel/Nedaplatin	Sensitive
17	60	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
18	63	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
19	67	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
20	58	III	Serous	II	Paclitaxel/Oxaliplatin	Sensitive
21	58	III	Serous	III	Paclitaxel/Oxaliplatin	Resistance
22	56	III	Serous	II	Paclitaxel/Oxaliplatin	Resistance
23	63	III	Serous	II	Paclitaxel/Oxaliplatin	Resistance
24	63	III	Serous	III	Paclitaxel/Nedaplatin	Resistance
25	68	IV	Serous	II	Paclitaxel/ Carboplatin	Resistance
26	50	III	Serous	III	Paclitaxel/Oxaliplatin	Resistance
27	48	III	Serous	III	Paclitaxel / Carboplatin	Resistance
28	49	III	Serous	III	Paclitaxel/ Nedaplatin	Resistance
29	63	IV	Serous	II	Paclitaxel/ Nedaplatin	Resistance
30	56	III	Endometrioid	III	Paclitaxel/Oxaliplatin	Resistance
31	61	IV	Serous	II	Paclitaxel/Nedaplatin	Resistance
32	40	II	Serous	II	Paclitaxel/Nedaplatin	Resistance
33	50	III	Serous	II	Paclitaxel/Oxaliplatin	Resistance
34	65	III	Serous	II	Paclitaxel/Oxaliplatin	Resistance
35	59	III	Serous	II	Paclitaxel/Oxaliplatin	Resistance
36	40	IV	Serous	II	Paclitaxel/Oxaliplatin	Resistance
37	62	III	Serous	II	Paclitaxel/ Carboplatin	Resistance
38	46	III	Serous	II	Paclitaxel/Oxaliplatin	Resistance
39	52	III	Serous	II	Paclitaxel/Oxaliplatin	Resistance
40	53	III	Serous	II	Paclitaxel/Nedaplatin	Resistance

A is graded according to the degree of differentiation (I-low grade, II- middle grade, III- high grade)

Back to article page

ISSN: 1757-2215

Contact us

General enquiries: journalsubmissions@springernature.com